MX2021006138A - Otros compuestos heteroaromaticos que tienen actividad contra el vrs. - Google Patents

Otros compuestos heteroaromaticos que tienen actividad contra el vrs.

Info

Publication number
MX2021006138A
MX2021006138A MX2021006138A MX2021006138A MX2021006138A MX 2021006138 A MX2021006138 A MX 2021006138A MX 2021006138 A MX2021006138 A MX 2021006138A MX 2021006138 A MX2021006138 A MX 2021006138A MX 2021006138 A MX2021006138 A MX 2021006138A
Authority
MX
Mexico
Prior art keywords
activity against
compounds
heteroaromatic compounds
against rsv
further heteroaromatic
Prior art date
Application number
MX2021006138A
Other languages
English (en)
Inventor
Patrick René Angibaud
Guillaume Jean Maurice Mercey
Antoine Benjamin Michaut
Pierre Jean- Marie Bernard RABOISSON
Peter Rigaux
Jérome Émile Georges Guillemont
Sovy Chao
David Francis Alain Lancois
Original Assignee
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Unlimited Co filed Critical Janssen Sciences Ireland Unlimited Co
Publication of MX2021006138A publication Critical patent/MX2021006138A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La invención trata sobre compuestos de fórmula (I) que tienen actividad antivírica, en particular, que tienen una actividad inhibidora sobre la replicación del virus respiratorio sincicial (VRS); la invención trata además sobre composiciones farmacéuticas que comprenden estos compuestos y los compuestos para su uso en el tratamiento o la prevención de una infección por el virus respiratorio sincicial.
MX2021006138A 2018-11-26 2019-11-25 Otros compuestos heteroaromaticos que tienen actividad contra el vrs. MX2021006138A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18208276 2018-11-26
PCT/EP2019/082404 WO2020109224A1 (en) 2018-11-26 2019-11-25 Further heteroaromatic compounds having activity against rsv

Publications (1)

Publication Number Publication Date
MX2021006138A true MX2021006138A (es) 2021-06-23

Family

ID=64476997

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021006138A MX2021006138A (es) 2018-11-26 2019-11-25 Otros compuestos heteroaromaticos que tienen actividad contra el vrs.

Country Status (13)

Country Link
US (1) US20220033396A1 (es)
EP (1) EP3887372B1 (es)
JP (1) JP2022507779A (es)
KR (1) KR20210096111A (es)
CN (1) CN113166146A (es)
AU (1) AU2019389616A1 (es)
BR (1) BR112021009309A2 (es)
CA (1) CA3115595A1 (es)
EA (1) EA202191482A1 (es)
ES (1) ES2934054T3 (es)
MA (1) MA54286A (es)
MX (1) MX2021006138A (es)
WO (1) WO2020109224A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7305658B2 (ja) 2018-01-31 2023-07-10 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 抗ｒｓｖ活性を有するシクロアルキル置換ピラゾロピリミジン
AU2019260109B2 (en) 2018-04-23 2023-07-13 Janssen Sciences Ireland Unlimited Company Heteroaromatic compounds having activity against RSV

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006125101A2 (en) * 2005-05-20 2006-11-23 Array Biopharma Inc. Raf inhibitor compounds and methods of use thereof
EP2217069A4 (en) * 2007-11-09 2012-03-14 Salk Inst For Biological Studi INHIBITORS OF NON-NUCLEOSIDE INHIBITORS OF THE REVERSE TRANSCRIPTASE
JP6122868B2 (ja) * 2011-12-22 2017-04-26 ギリアード サイエンシーズ， インコーポレイテッド 抗ウイルス剤としてのピラゾロ［１，５−ａ］ピリミジン
US9981976B2 (en) * 2014-12-08 2018-05-29 Janssen Sciences Ireland Uc Piperidine substituted pyrazolo[1,5-A]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (RSV)
JO3637B1 (ar) 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv

Also Published As

Publication number Publication date
CA3115595A1 (en) 2020-06-04
BR112021009309A2 (pt) 2021-08-10
EP3887372A1 (en) 2021-10-06
AU2019389616A1 (en) 2021-04-29
US20220033396A1 (en) 2022-02-03
ES2934054T3 (es) 2023-02-16
KR20210096111A (ko) 2021-08-04
EP3887372B1 (en) 2022-10-12
CN113166146A (zh) 2021-07-23
MA54286A (fr) 2021-10-06
EA202191482A1 (ru) 2021-12-14
JP2022507779A (ja) 2022-01-18
WO2020109224A1 (en) 2020-06-04

Similar Documents

Publication Publication Date Title
PH12017501958B1 (en) Rsv antiviral pyrazolo- and triazolo-pyrimidine compounds
ZA202002139B (en) Combination pharmaceutical agents as rsv inhibitors
PH12018501962A1 (en) Stablizied soluble pre-fusion rsv f proteins
MX368162B (es) Derivados de pirazolo[1,5-a]pirimidina sustituida con piperidina con actividad inhibidora sobre la replicacion del virus sincicial respiratorio (vsr).
NZ733174A (en) Quinazoline derivatives used to treat hiv
PH12021551268A1 (en) 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same
MX2021005607A (es) Proteinas f de prefusion del vrs estabilizadas.
PH12018502332A1 (en) Stabilized pre-fusion rsv f proteins
MX2020011200A (es) Compuestos heteroaromaticos que tienen actividad contra vrs.
PH12019502601A1 (en) Therapeutic compounds and compositions, and methods of use thereof
MX2021014301A (es) Otros compuestos heteroaromaticos que tienen actividad contra el vrs.
MX2021006138A (es) Otros compuestos heteroaromaticos que tienen actividad contra el vrs.
PH12017500558A1 (en) 4'-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus rna replication
PH12020550673A1 (en) Pyrazolopyrimidines having activity against the respiratory syncytial virus (rsv)
EP4234021A3 (en) Pharmaceutical composition comprising an adenosine derivative for use in the prevention or treatment of diabetic nephropathy
MX2020008061A (es) Pirazolopirimidinas sustituidas con cicloalquilo que tienen actividad contra vrs.
WO2015130547A8 (en) Bis-cyclic guanidine compound compositions, methods of use and treatment thereof
MX2017007430A (es) Derivados triciclicos de pirazolo [1,5-a]pirimidina sustituidos con piperidina con actividad inhibidora en la replicacion del virus sincitial respiratorio (vsr).
WO2016072854A3 (en) Pantothenamide analogues
AU2014298561A8 (en) Substituted pyridine-piperazinyl analogues as RSV antiviral compounds
EA202191384A1 (ru) 3,3-дифтораллиламины или их соли и содержащие их фармацевтические композиции
PL428024A1 (pl) Sulfonowana pochodna polistyrenu do zastosowania w leczeniu i/lub profilaktyce infekcji wywołanej przez kociego herpeswirusa